Gildas Prié

541 total citations
22 papers, 413 citations indexed

About

Gildas Prié is a scholar working on Organic Chemistry, Molecular Biology and Pharmaceutical Science. According to data from OpenAlex, Gildas Prié has authored 22 papers receiving a total of 413 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Organic Chemistry, 6 papers in Molecular Biology and 5 papers in Pharmaceutical Science. Recurrent topics in Gildas Prié's work include Chronic Myeloid Leukemia Treatments (5 papers), Fluorine in Organic Chemistry (5 papers) and Synthesis and pharmacology of benzodiazepine derivatives (4 papers). Gildas Prié is often cited by papers focused on Chronic Myeloid Leukemia Treatments (5 papers), Fluorine in Organic Chemistry (5 papers) and Synthesis and pharmacology of benzodiazepine derivatives (4 papers). Gildas Prié collaborates with scholars based in France, United Kingdom and Morocco. Gildas Prié's co-authors include Fabrice Gouilleux, Marie‐Claude Viaud‐Massuard, Michael Shipman, Jerome F. Hayes, Alain Duchêne, Jean‐Luc Parrain, Heather Twin, Sébastien Papot, Florian Hamon and Cécile Croix and has published in prestigious journals such as Angewandte Chemie International Edition, International Journal of Molecular Sciences and Journal of Medicinal Chemistry.

In The Last Decade

Gildas Prié

21 papers receiving 408 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gildas Prié France 11 257 115 63 51 44 22 413
Aaron Kunzer United States 8 195 0.8× 302 2.6× 74 1.2× 18 0.4× 28 0.6× 11 472
Paul Rafferty United Kingdom 14 221 0.9× 168 1.5× 70 1.1× 20 0.4× 13 0.3× 21 413
Stephen C. Yabut United States 10 205 0.8× 210 1.8× 37 0.6× 50 1.0× 8 0.2× 14 417
Debasmita Saha India 13 380 1.5× 140 1.2× 26 0.4× 14 0.3× 39 0.9× 33 526
Baptiste Ronan France 12 344 1.3× 260 2.3× 26 0.4× 24 0.5× 14 0.3× 13 739
Adrian D. Hobson United States 9 204 0.8× 130 1.1× 116 1.8× 13 0.3× 11 0.3× 25 385
Masahiko Hagihara Japan 9 378 1.5× 370 3.2× 48 0.8× 15 0.3× 34 0.8× 15 579
Uwe Trinks Switzerland 7 241 0.9× 217 1.9× 111 1.8× 38 0.7× 12 0.3× 10 414
Songwen Lin China 14 253 1.0× 288 2.5× 92 1.5× 14 0.3× 13 0.3× 37 544
Ramil Baiazitov United States 9 192 0.7× 385 3.3× 207 3.3× 30 0.6× 10 0.2× 15 666

Countries citing papers authored by Gildas Prié

Since Specialization
Citations

This map shows the geographic impact of Gildas Prié's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gildas Prié with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gildas Prié more than expected).

Fields of papers citing papers by Gildas Prié

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gildas Prié. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gildas Prié. The network helps show where Gildas Prié may publish in the future.

Co-authorship network of co-authors of Gildas Prié

This figure shows the co-authorship network connecting the top 25 collaborators of Gildas Prié. A scholar is included among the top collaborators of Gildas Prié based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gildas Prié. Gildas Prié is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Croix, Cécile, et al.. (2024). Targeted Therapeutic Strategies for the Treatment of Cancer. Cancers. 16(2). 461–461. 33 indexed citations
2.
Croix, Cécile, et al.. (2024). Novel antileukemic compound with sub-micromolar potency against STAT5 addicted myeloid leukemia cells. European Journal of Medicinal Chemistry. 284. 117211–117211.
3.
Gouilleux, Fabrice, et al.. (2020). VAS3947 Induces UPR-Mediated Apoptosis through Cysteine Thiol Alkylation in AML Cell Lines. International Journal of Molecular Sciences. 21(15). 5470–5470. 7 indexed citations
4.
Viaud‐Massuard, Marie‐Claude, et al.. (2020). Inhibitors Targeting STAT5 Signaling in Myeloid Leukemias: New Tetrahydroquinoline Derivatives with Improved Antileukemic Potential. ChemMedChem. 16(6). 1034–1046. 6 indexed citations
5.
Neubauer, Heidi A., et al.. (2020). Pharmacological Inhibition of Oncogenic STAT3 and STAT5 Signaling in Hematopoietic Cancers. Cancers. 12(1). 240–240. 52 indexed citations
6.
Vallet, Nicolas, Olivier Hérault, Frédéric Mazurier, et al.. (2019). A Novel Inhibitor of STAT5 Signaling Overcomes Chemotherapy Resistance in Myeloid Leukemia Cells. Cancers. 11(12). 2043–2043. 18 indexed citations
7.
Bourgeais, Jérôme, et al.. (2017). New Inhibitor Targeting Signal Transducer and Activator of Transcription 5 (STAT5) Signaling in Myeloid Leukemias. Journal of Medicinal Chemistry. 60(14). 6119–6136. 19 indexed citations
8.
Jorda, Radek, Christophe Marot, Karel Berka, et al.. (2015). Synthesis, biological evaluation and molecular modeling of a novel series of 7-azaindole based tri-heterocyclic compounds as potent CDK2/Cyclin E inhibitors. European Journal of Medicinal Chemistry. 108. 701–719. 33 indexed citations
9.
Croix, Cécile, et al.. (2015). Rhodium-Catalyzed 1,4-Addition of Arylboronic Acids to 3-Benzylidene-1H-pyrrolo[2,3-b]pyridin-2(3H)-one Derivatives. The Journal of Organic Chemistry. 80(6). 3264–3269. 7 indexed citations
10.
Mélin, C., Nathalie Blanc, Arnaud Lanoue, et al.. (2014). Disrupting the methionine biosynthetic pathway in Candida guilliermondii: characterization of the MET2 gene as counter‐selectable marker. Yeast. 31(7). 243–251. 7 indexed citations
11.
12.
Prié, Gildas, et al.. (2012). A novel and convenient method for the synthesis of new derivatives of pyrido[3,2-e]pyrrolo[1,2-a][1,4]diazepine-6,11-dione. Tetrahedron. 68(47). 9572–9577. 5 indexed citations
13.
14.
Hamon, Florian, et al.. (2009). Cyanuric chloride: an efficient reagent for the Lossen rearrangement. Tetrahedron Letters. 50(49). 6800–6802. 43 indexed citations
15.
Prié, Gildas, et al.. (2004). A Lewis Acid Catalyzed Intramolecular [4+3] Cycloaddition Route to Polycyclic Systems That Contain a Seven‐Membered Ring. Angewandte Chemie International Edition. 43(47). 6517–6519. 61 indexed citations
16.
Prié, Gildas, et al.. (2004). A Lewis Acid Catalyzed Intramolecular [4+3] Cycloaddition Route to Polycyclic Systems That Contain a Seven‐Membered Ring. Angewandte Chemie. 116(47). 6679–6681. 19 indexed citations
17.
Prié, Gildas, et al.. (2003). A New Synthesis of Optically Active 3‐Substituted (3S)‐3,4‐Dihydro‐5‐(perfluoroalkyl)‐2H‐[1,4]oxazepin‐7‐ones. Helvetica Chimica Acta. 86(3). 726–732. 10 indexed citations
18.
Prié, Gildas, et al.. (2002). Easy synthesis of (E)- or (Z)-perfluorinated β-enaminoesters. Journal of Fluorine Chemistry. 117(1). 35–41. 9 indexed citations
19.
Thibonnet, J., Gildas Prié, Mohamed Abarbri, Alain Duchêne, & Jean‐Luc Parrain. (1999). Synthesis of ethyl (13E)-trifluoromethylretinoate and its analogues by palladium-catalysed cross-coupling. Tetrahedron Letters. 40(16). 3151–3154. 26 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aaron Kunzer Breakdown of academic impact, for papers by Paul Rafferty Breakdown of academic impact, for papers by Stephen C. Yabut Breakdown of academic impact, for papers by Debasmita Saha Breakdown of academic impact, for papers by Baptiste Ronan Breakdown of academic impact, for papers by Adrian D. Hobson Breakdown of academic impact, for papers by Masahiko Hagihara Breakdown of academic impact, for papers by Uwe Trinks Breakdown of academic impact, for papers by Songwen Lin Breakdown of academic impact, for papers by Ramil Baiazitov
Rankless by CCL
2026